Valued EpiGenetic Glycemic ImprovEments Through Weight Loss (VEGGIE)
Sponsor: Medifast, Inc.
This NA trial investigates Obesity and Pre-diabetes and is currently completed. Medifast, Inc. leads this study, which shows 12 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Sep 2020 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Recruiting NA
-
Feb 2019 — Jan 2020 [monthly]
Recruiting NA
-
Aug 2018 — Feb 2019 [monthly]
Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Mar 2018 [monthly]
Recruiting NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medifast, Inc.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .